Alkermes plc (NASDAQ: ALKS) on Tuesday, plunged -4.41% from the previous trading day, before settling in for the closing price of $29.49. Within the past 52 weeks, ALKS’s price has moved between $22.90 and $36.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 7.94% over the last five years. The company achieved an average annual earnings per share of -36.84%. With a float of $160.59 million, this company’s outstanding shares have now reached $162.18 million.
The firm has a total of 1800 workers. Let’s measure their productivity. In terms of profitability, gross margin is 84.25%, operating margin of 27.0%, and the pretax margin is 28.49%.
Alkermes plc (ALKS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Alkermes plc is 2.57%, while institutional ownership is 101.33%. The most recent insider transaction that took place on Feb 28 ’25, was worth 65,892. In this transaction VP, Finance (Interim PAO) of this company sold 1,938 shares at a rate of $34.00, taking the stock ownership to the 7,717 shares. Before that another transaction happened on Feb 25 ’25, when Company’s VP, Finance (Interim PAO) sold 3,743 for $35.26, making the entire transaction worth $131,978. This insider now owns 7,717 shares in total.
Alkermes plc (ALKS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -36.84% per share during the next fiscal year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Alkermes plc (ALKS) is currently performing well based on its current performance indicators. A quick ratio of 2.65 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.98. Likewise, its price to free cash flow for the trailing twelve months is 11.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.18, a number that is poised to hit 0.28 in the next quarter and is forecasted to reach 1.86 in one year’s time.
Technical Analysis of Alkermes plc (ALKS)
Analysing the last 5-days average volume posted by the [Alkermes plc, ALKS], we can find that recorded value of 1.79 million was better than the volume posted last year of 1.7 million. As of the previous 9 days, the stock’s Stochastic %D was 9.61%. Additionally, its Average True Range was 1.22.
During the past 100 days, Alkermes plc’s (ALKS) raw stochastic average was set at 11.56%, which indicates a significant increase from 3.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.47% in the past 14 days, which was lower than the 30.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.40, while its 200-day Moving Average is $29.17. Now, the first resistance to watch is $29.56. This is followed by the second major resistance level at $30.94. The third major resistance level sits at $31.77. If the price goes on to break the first support level at $27.35, it is likely to go to the next support level at $26.52. Now, if the price goes above the second support level, the third support stands at $25.14.
Alkermes plc (NASDAQ: ALKS) Key Stats
Market capitalization of the company is 4.65 billion based on 164,836K outstanding shares. Right now, sales total 1,558 M and income totals 367,070 K. The company made 429,990 K in profit during its latest quarter, and 146,500 K in sales during its previous quarter.
